Digitalized Diabetes and SARS-CoV-2 Guidelines | RAMP News

Being affected by the SARS-CoV-2 means an increased risk for hospitalizations and death to type 2 diabetes, hypertension and cardiovascular disease patients. For this reason, the German Diabetes Society (Deutsche Diabetes Gesellschaft) has updated its medical guidelines to treat diabetes patients that are infected with SARS-CoV-2.

Our scientists analyzed and digitalized these updates, helping our AI to follow the guidelines, and help doctors with their therapy decision.

The updates of the German Diabetes Society guidelines for SARS-CoV-2 are in the RAMP therapy decision support tool. To see how this disease affects current medications or future ones, it is as easy as activating a filter or entering the symptoms, for example: your patient’s body temperature of 38.8ºC.

Register here

Image by Luke Chesser

Henisaja GmbH
Kastanienallee 61
10119 Berlin

Geschäftsführung: Helene Schönewolf

Telefonnummer: +49 (0) 30 31 98 08 52

Eingetragen beim Amtsgericht Berlin Charlottenburg unter HRB 167143 B ​
Umsatzsteuer ID: DE299921795